John McIlwain, CEO
In the pharmaceutical industry, the majority of clinical trials are conducted using Electronic Data Capture (EDC) software. On one hand, EDC has replaced paper-based data approaches to streamline data collection and expedite the time to market for drugs and medical devices. On the other hand, traditional EDC still involves a lot of manual effort and work duplication on the part of research sites. Sites essentially key punch data into EDC systems from source documents. In the traditional EDC model, the systems used at the sites are generally never integrated with the EDC systems. Consequently, at the sites where clinical trials are fulfilled and where there is the greatest opportunity for improvement —traditional EDC has done little to make work more efficient. Some would say it adds to the workload. “Even though EDC is widely adopted by pharmaceutical companies and Clinical Research Organizations (CRO), sites using EDC are still performing largely manual and often duplicative activities to fulfill clinical trials,” begins John Mcllwain, CEO, Velos.
Located in Fremont, Velos integrates the clinical, administrative and financial information needs of clinical research management with their flagship offering, Velos eResearch, a SaaS platform.
Through connected data sources and using the same system that sites use in their daily clinical research operations, it is possible for Velos clinical teams to eliminate double data entry and deliver study data directly to sponsors
“Through connected data sources and using the same system that sites use in their daily clinical research operations, it is possible for Velos clinical teams to eliminate double data entry and deliver study data directly to sponsors,” delineates Mcllwain. “We call this Direct Data Capture. The system also helps research sites manage their entire clinical research portfolio including study administration, status management, patient enrollment, calendars, budgeting, and billing. What’s more, the same product line can be used by the sites to create patient clinical profiles that may include diagnosis, lab results, orders, family histories, biospecimen information, and registries. This enables quick access to valuable research information in a controlled and secure environment,” adds Mcllwain.
Velos customers include more than 60 large academic medical centers, health systems, and other research sites conducting thousands of clinical trials.
In the U.S., nearly half of NIH funding goes to Velos customers.
One Velos customer is the Norris Cotton Cancer Center (NCCC) at Dartmouth College in New Hampshire. NCCC uses Velos eResearch to manage most aspects of their clinical trials. Having Velos eResearch integrated with their medical record system, physicians get direct access at the point of care to a complete overview about the patient’s condition from the day of his enrollment to the present stage.
Since 2007, Velos eResearch has also been the enterprise software platform for the National Cancer Center of South Korea (NCC). The NCC uses the system for clinical and non-clinical tasks in electronic Case Report Form (eCRF) development, data management, and analysis, and is operating Velos eResearch to serve public interest. The NCC of South Korea and Velos have just renewed a seven year agreement to expand use of Velos eResearch for cancer research nationally. Over 100 large-scale clinical trials have been conducted on the Velos platform with no need for third party EDC vendors.
The company continuously expands its range of capabilities under Mcllwain’s leadership. A sports enthusiast who plays football and hockey, Mcllwain believes that 'only a team effort can win the match.' “At Velos, team members have been working collaboratively with our customers to create an integrated clinical research information supply chain that has the potential to transform the information model in clinical research to a whole new level of value and efficiency,” concludes Mcllwain on an optimistic note.